SHAPING THE FUTURE OF BEAUTY
STIMULATE SCIENTIFIC RESEARCH, ENCOURAGE INNOVATION AND CONTRIBUTE TO PROGRESS IN DERMATOLOGY
Galénic is a scientific pioneer force in the skincare industry, committed to merging the world of beauty with the power of scientific innovation.
We are profoundly persuaded that innovation requires active collaboration, harnessing the power of collective knowledge and skills to achieve significant transformations.
At the heart of this approach is the GALENIC DERMATOLOGY RESEARCH FUND, an endowment fund created last September 2023 with the aim of encouraging innovation in dermatology, engaging the brand into scientific progress in the field and enabling, in the future, the creation of cutting-edge, high-quality products.
“In a world where innovation is the driving force behind change, novelty, originality, and invention ; collaboration and partnerships play a pivotal role in shaping the path forward. We believe that the
journey to innovation excellence is a collective effort because it leverages the power of collective knowledge, skills, and creativity to drive meaningful changes. [...]
The skin, our canvas, holds the secrets of beauty and well-being, and we are determined to unlock its full potential."
Sarah Stevens - Galénic, General Director Europe
"Throughout my years as a dermatology doctor and researcher, I believe that science and innovation go hand in hand. They drive progress, pushing the limits of what is possible. However, to be able to have enough resources for research, partnerships and funding are also important to make science move forward."
Professor Jean-David Bouaziz, President of the Scientific Committee, Galenic Dermatology Research Fund
Back to the 2026 edition
The fund aims to invest in groundbreaking projects led by French researchers, awarded four individual grants.
Applications in 2026, submitted by academic researchers, doctors or professors, were required to demonstrate a potential scientific breakthrough in dermatology within one of the following areas:
1. Understanding the skin's barrier function,
2. Knowledge of skin aging mechanisms (chrono-aging and photoaging),
3. Research on bioavailability and penetration of ingredients and active principles into the skin,
4. Cutaneous functional pharmacology with new ingredient and/or active ingredient leads,
5. Characterization of new cutaneous biological and biotechnological active ingredients (excluding drugs).
The four selected projects, chosen for their relevance, scientific interest and uniqueness, were carefully evaluated by the endowment fund's Scientific Committee.
A MULTIDISCIPLINARY, INTERNATIONAL SCIENTIFIC COMMITTEE
The GALENIC DERMATOLOGY RESEARCH FUND Scientific Committee was composed of eminent personalities from the most prestigious French scientific institutions in the field of dermatology and experts in cosmetic research and development:
- Pr Jean-David BOUAZIZ, MD-PhD, President of the Scientific Committee and Head of the Dermatology Department at Hôpital Saint-Louis, Paris. Coordinator of an expert center, he is also a clinician and clinical trial
investigator at this same hospital - Pr Katia BONIFACE, PhD, professor of Therapeutic Innovations at the University of Bordeaux and member of the ImmunoConcEpT Laboratory (CNRS UMR 5164), a research unit of this same university
- Dr Romain FONTAINE, PhD, co-director of the "Skin Biology" laboratory and co-director of the "Genetic and Cellular Plasticity" research axis at the Institut Cochin, Paris
- Dr Hélène Le BUANEC, Immunology research officer at Hôpital Saint-Louis, Paris
- Dr Soline ESTRACH, PhD, Research Scientist at the Institute for Research on Cancer and Aging (IRCAN), Université Côte d’Azur
- Jing CHENG is Chief Scientific Officer of the Yatsen Group, with over 25 years' experience in Research & Development in the cosmetics industry
- Pr Yao MIN, PhD, Leader, Department of Burn & Plastic Surgery, NO.9 people’s hospital affiliated to shanghai Jiao Tong University School of Medicine
2026 Edition Projects Recognized for Their Potential Impact on Scientific Research
- Dr Violaine SÉE – Scientific Lead
CNRS UMR 5305, Institute of Biology and Protein Chemistry / Tissue Biology and Therapeutic Engineering Laboratory (LBTI), Lyon
Elucidating the impact of hypoxia signaling on keratinocyte functions and its regulation during aging
- Dr Laura SALAVESSA – Scientific Lead
Institut Necker–Enfants Malades, INSERM U1151, CNRS UMR8253 – Paris
Melanin particles associated with extracellular vesicles: novel players in pigmentation and skin homeostasis (EVoMEL)
- Dr Patricia ROUSSELLE – Scientific Lead
Tissue Biology and Therapeutic Engineering Laboratory – UMR 5305, CNRS / Université Lyon 1
Tight junctions: the new frontier of the skin barrier
- Dr Agnès RIOUX BILAN – Scientific Lead
Laboratory of Inflammation, Epithelial Tissues and Cytokines (LITEC) [UR 15560] – Poitiers
Role of fibroblasts in epidermal wound healing
- Dr Stéphanie MATAR – Scientific Lead
Cochin Institute, Skin Biology Team, Inserm U1016 – Paris
Role of peripheral serotonin in skin homeostasis and wound healing: towards targeted therapeutic modulation
- Dr Charles CASSIUS
Saint-Louis Research Institute – INSERM U1342, Skin Immunity and Inflammation Team, Paris
WIN2-HS – Dysregulation of non-canonical WNT signaling in dermal fibroblasts in hidradenitis suppurativa
want to shape the future of beauty through science?
The aim of the Galénic Dermatology Research Fund is to reward research and innovation projects demonstrating a significant scientific advance in dermatology.
Galénic invites researchers and professionals who have a groundbreaking research project in dermatology, to join us in this exciting journey of innovation to shape the future of beauty.